Lidgate, D M <br/><br/>
Formulation of vaccine adjuvant muramyldipeptides. 3. Processing optimization, characterization, and bioactivity of an emulsion vehicle.  [electronic resource] 

 -  Pharmaceutical research  Sep 1989 
 - 748-52 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0724-8741 
<br/><br/><label>Standard No.: </label>10.1023/a:1015915212195  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acetylmuramyl-Alanyl-Isoglutamine--adverse effects<br/>Adjuvants, Immunologic--adverse effects<br/>Animals<br/>Chemical Phenomena<br/>Chemistry<br/>Emulsions<br/>Guinea Pigs<br/>Indicators and Reagents<br/>Irritants<br/>Male<br/>Microscopy, Electron, Scanning<br/>Muscular Diseases--chemically induced<br/>Particle Size<br/>Pharmaceutical Vehicles<br/>Time Factors